Literature DB >> 18182382

Regulation of histone H4 acetylation by transcription factor E2A in Ig gene conversion.

Hiroyuki Kitao1, Masayo Kimura, Kazuhiko Yamamoto, Hidetaka Seo, Keiko Namikoshi, Yasutoshi Agata, Kunihiro Ohta, Minoru Takata.   

Abstract

Recent studies implicate the transcription factor E2A in Ig diversification such as somatic hypermutation or gene conversion (GCV). GCV also requires active Ig transcription, expression of the activation-induced deaminase (AID) and a set of homologous recombination factors. We have disrupted the E2A gene in the chicken B-cell line DT40 and found greatly diminished rate of GCV without changes in the levels of transcripts from AID and Ig heavy chain or Ig light chain (IgL) genes. However, chromatin immunoprecipitation analysis revealed that the loss of E2A accompanies drastically reduced acetylation levels of the histone H4 in rearranged IgL locus. Furthermore, the defects in GCV were restored by trichostatin A treatment, which raised H4 acetylation to the normal levels. Thus, E2A may contribute to GCV by maintaining histone acetylation, which could be a prerequisite for targeting or full deaminase function of AID.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182382     DOI: 10.1093/intimm/dxm140

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

1.  E2A acts in cis in G1 phase of cell cycle to promote Ig gene diversification.

Authors:  Munehisa Yabuki; Ellen C Ordinario; W Jason Cummings; Monica M Fujii; Nancy Maizels
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 2.  Epigenetics of the antibody response.

Authors:  Guideng Li; Hong Zan; Zhenming Xu; Paolo Casali
Journal:  Trends Immunol       Date:  2013-05-02       Impact factor: 16.687

Review 3.  Activation-induced cytidine deaminase-mediated hypermutation in the DT40 cell line.

Authors:  Hiroshi Arakawa; Jean-Marie Buerstedde
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

4.  A critical context-dependent role for E boxes in the targeting of somatic hypermutation.

Authors:  Jessica J McDonald; Jukka Alinikula; Jean-Marie Buerstedde; David G Schatz
Journal:  J Immunol       Date:  2013-07-08       Impact factor: 5.422

5.  Histone H2A and H2B are monoubiquitinated at AID-targeted loci.

Authors:  Glen M Borchert; Nathaniel W Holton; Kevin A Edwards; Laura A Vogel; Erik D Larson
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

6.  Predisposition to cancer caused by genetic and functional defects of mammalian Atad5.

Authors:  Daphne W Bell; Nilabja Sikdar; Kyoo-Young Lee; Jessica C Price; Raghunath Chatterjee; Hee-Dong Park; Jennifer Fox; Masamichi Ishiai; Meghan L Rudd; Lana M Pollock; Sarah K Fogoros; Hassan Mohamed; Christin L Hanigan; Suiyuan Zhang; Pedro Cruz; Gabriel Renaud; Nancy F Hansen; Praveen F Cherukuri; Bhavesh Borate; Kirk J McManus; Jan Stoepel; Payal Sipahimalani; Andrew K Godwin; Dennis C Sgroi; Maria J Merino; Gene Elliot; Abdel Elkahloun; Charles Vinson; Minoru Takata; James C Mullikin; Tyra G Wolfsberg; Philip Hieter; Dae-Sik Lim; Kyungjae Myung
Journal:  PLoS Genet       Date:  2011-08-25       Impact factor: 5.917

Review 7.  Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response.

Authors:  Hong Zan; Paolo Casali
Journal:  Front Immunol       Date:  2015-12-14       Impact factor: 7.561

8.  Genetic diversification by somatic gene conversion.

Authors:  Kohei Kurosawa; Kunihiro Ohta
Journal:  Genes (Basel)       Date:  2011-01-10       Impact factor: 4.096

9.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

10.  Identification of core DNA elements that target somatic hypermutation.

Authors:  Kristin M Kohler; Jessica J McDonald; Jamie L Duke; Hiroshi Arakawa; Sally Tan; Steven H Kleinstein; Jean-Marie Buerstedde; David G Schatz
Journal:  J Immunol       Date:  2012-10-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.